PanGen Biotech (Korea) Probability of Future Stock Price Finishing Under 6,122

222110 Stock  KRW 6,000  290.00  4.61%   
PanGen Biotech's future price is the expected price of PanGen Biotech instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of PanGen Biotech performance during a given time horizon utilizing its historical volatility. Check out PanGen Biotech Backtesting, PanGen Biotech Valuation, PanGen Biotech Correlation, PanGen Biotech Hype Analysis, PanGen Biotech Volatility, PanGen Biotech History as well as PanGen Biotech Performance.
  
Please specify PanGen Biotech's target price for which you would like PanGen Biotech odds to be computed.

PanGen Biotech Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of PanGen Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for PanGen Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
PanGen Biotech is way too risky over 90 days horizon
PanGen Biotech appears to be risky and price may revert if volatility continues
The company reported the revenue of 7.94 B. Net Loss for the year was (3.31 B) with profit before overhead, payroll, taxes, and interest of 1.35 B.
PanGen Biotech has accumulated about 8.9 B in cash with (3.32 B) of positive cash flow from operations.
Roughly 33.0% of the company shares are owned by insiders or employees

PanGen Biotech Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of PanGen Stock often depends not only on the future outlook of the current and potential PanGen Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. PanGen Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding10.7 M
Cash And Short Term Investments23.9 B
Shares Float5.6 M

PanGen Biotech Technical Analysis

PanGen Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. PanGen Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of PanGen Biotech. In general, you should focus on analyzing PanGen Stock price patterns and their correlations with different microeconomic environments and drivers.

PanGen Biotech Predictive Forecast Models

PanGen Biotech's time-series forecasting models is one of many PanGen Biotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary PanGen Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about PanGen Biotech

Checking the ongoing alerts about PanGen Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for PanGen Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
PanGen Biotech is way too risky over 90 days horizon
PanGen Biotech appears to be risky and price may revert if volatility continues
The company reported the revenue of 7.94 B. Net Loss for the year was (3.31 B) with profit before overhead, payroll, taxes, and interest of 1.35 B.
PanGen Biotech has accumulated about 8.9 B in cash with (3.32 B) of positive cash flow from operations.
Roughly 33.0% of the company shares are owned by insiders or employees

Other Information on Investing in PanGen Stock

PanGen Biotech financial ratios help investors to determine whether PanGen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PanGen with respect to the benefits of owning PanGen Biotech security.